Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study) - eClinicalMedicine
See @TCCInsightTeam's Tweet on May 13, 2022 on Twitter / Twitter
.jpg?csf=1&web=1&e=dTEB7V "Immune boosting antibody trialled in patients with oesophageal cancer | Southampton Clinical Trials Unit | University of Southampton")
Immune boosting antibody trialled in patients with oesophageal cancer | Southampton Clinical Trials Unit | University of Southampton
Men's oesophageal cancer risk "triple that of women" - PMLiVE
Oesophageal cancer: risks, prevention, and diagnosis | The BMJ
A trial looking at improving chemoradiotherapy for people with cancer of the food pipe (SCOPE 2) | Cancer Research UK
COG : Gefitinib for oesophageal cancer progressing after chemotherapy — Department of Oncology
Oesophageal cancer risk | Cancer Research UK
Stage 0 (high grade dysplasia) | Oesophageal cancer | Cancer Research UK
Cell-free DNA analysis in current cancer clinical trials: a review | British Journal of Cancer
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial - The Lancet Oncology
Neoadjuvant cisplatin and fluorouracil versus epirubicin, cisplatin, and capecitabine followed by resection in patients with oesophageal adenocarcinoma (UK MRC OE05): an open-label, randomised phase 3 trial - The Lancet Oncology
Regulatory and clinical consequences of negative confirmatory trials of accelerated approval cancer drugs: retrospective observational study | The BMJ
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Advances in targeted therapy for esophageal cancer | Signal Transduction and Targeted Therapy
UK NICE recommends BMS' nivolumab for oesophageal cancer
Cancers | Free Full-Text | The Landscape of CAR-T Cell Clinical Trials against Solid Tumors—A Comprehensive Overview
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
New option to treat advanced oesophageal cancer approved for NHS in Scotland - Cancer Research UK - Cancer news
Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial - The Lancet Gastroenterology & Hepatology
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction - Annals of Oncology
The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 -
